Cell BiologybioRxivPreprint
Harmine Plus Exendin-4 Enhances Remission of Recent-Onset Type 1 Diabetes Following Anti-CD3 Therapy
Geming Lu, RANDY KANG, MIGUEL VARELA…·Adolfo Garcı́a-Ocaña
This study shows that harmine plus exendin-4, when combined with anti-CD3 therapy, promotes beta-cell recovery and reduces immunogenicity, leading to remission of recent-onset type 1 diabetes.
DOI 10.64898/2026.09.21.753317